Rangeley Capital »

89bio shares owned by Rangeley Capital

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $794k 54k 14.70

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding 89bio

RA Capital Management
Pentwater Capital Management
BlackRock
Deep Track Capital
Adage Capital Partners GP
Suvretta Capital Management
Vanguard Group
venBio Select Advisor
Glazer Capital
Henderson Group
State Street Corporation
Deutsche Bank Aktiengesellschaft
Westfield Capital Management Company
Geode Capital Management
LMR Partners

View all funds holding 89bio